|
MechanismGABAB receptor modulators |
|
|
|
|
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Voltaire Group UK Holdings Ltd.
0 Patents (Medical) associated with Voltaire Group UK Holdings Ltd.
100 Deals associated with Voltaire Group UK Holdings Ltd.
100 Translational Medicine associated with Voltaire Group UK Holdings Ltd.